Injection Drug Users and Viral Hepatitis
Injection drug users (IDUs) are at risk for Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infection through the sharing of needles and drug-preparation equipment. In addition, outbreaks of Hepatitis A infection have been reported among IDUs; such outbreaks are believed to occur through both percutaneous and fecal-oral routes. The Advisory Committee on Immunization Practices recommends that IDUs get vaccinated against Hepatitis A and Hepatitis B. Because of higher rates of infection among this population, CDC also recommends testing IDUs for chronic HBV and HCV infection.
Guidelines and Recommendations
Integrated Prevention Services for HIV Infection, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis for Persons Who Use Drugs Illicitly: Summary Guidance from CDC and the U.S. Department of Health and Human Services
Hepatitis B Vaccination Recommendations for Adults; Appendix
PDF version [PDF - 40 pages] (with appendices)
Technical Consultation Report